1 Correction to: Drugs (2020) 80:813–819 https://doi.org/10.1007/s40265-020-01302-2

Page 815, table 1, Efficacy of cemiplimab in adults with locally advanced or metastatic cutaneous squamous cell cancer in EMPOWER-CSCC 1: The title for the dosage on line 3, which previously read:


“Cemipliab 3 mg/kg once every 2 weeksb


should read:


“Cemiplimab 3 mg/kg once every 2 weeksb